SCHEMBL7528545

SCHEMBL7528545

Cc1ccc(NC2=CC(=O)OC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 4/20 0.41
POLB P06746 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
HPGD P15428 2/20 0.39
HTT P42858 3/20 0.38
TP53 P04637 2/20 0.38
MAPT P10636 2/20 0.38
TDP2 O95551 1/20 0.38
NSD2 O96028 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP3 P42574 1/20 0.38
BLM P54132 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7520380 0.82 MT-CO2 (0.51) KDM4ESMN1; SMN2LMNAPOLBALDH1A1
SCHEMBL7518230 0.82 KDM4E (0.40) KDM4ESMN1; SMN2LMNAALDH1A1RAB9A
SCHEMBL7517596 0.81 ALDH1A1 (0.54) KDM4ESMN1; SMN2TDP1LMNAPOLB
SCHEMBL7517550 0.81 MAPT (0.50) KDM4ESMN1; SMN2TDP1LMNAPOLB
SCHEMBL7518501 0.79 ALDH1A1 (0.46) SMN1; SMN2TDP1LMNAPOLBALDH1A1
SCHEMBL7524044 0.78 KIF11 (0.40) KDM4EMAPTMEN1KMT2ACA1
SCHEMBL7524238 0.78 RAPGEF4 (0.46) KDM4ESMN1; SMN2TDP1POLBALDH1A1
SCHEMBL7517906 0.72 KMT2A (0.38) KDM4EPOLBALDH1A1RAB9ANPC1
SCHEMBL7515459 0.70 IDO1 (0.43) ALDH1A1EGFRCA1RAPGEF4
SCHEMBL13492165 0.68 PTGS1 (0.41) ALDH1A1HPGDKMT2ACA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed